Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Am J Obstet Gynecol. 2020 Jun 23;223(6):898.e1–898.e16. doi: 10.1016/j.ajog.2020.06.039

Table 6.

The association between early onset (i.e., before menopause), late onset (i.e., after menopause) VMS and incident CVD, CHD and stroke

Vasomotor symptoms (VMS) CVD CHD Stroke
No. of CVD events No. of cases per 1000 person-years Adjusted hazard ratio (95% CI) No. of CHD events No. of cases per 1000 person-years Adjusted hazard ratio (95% CI) No. of stroke events No. of cases per 1000 person-years Adjusted hazard ratio (95% CI)
Hot flushes
 Never 128 8.1 1.00 113 7.2 1.00 21 1.5 1.00
 Early onset 1082 10.1 1.35 (1.09, 1.66) 959 8.9 1.41 (1.13, 1.77) 215 2 1.11 (0.69, 1.78)
 Late onset 633 11.5 1.64 (1.32, 2.05) 559 10.1 1.68 (1.33, 2.14) 120 2.3 1.45 (0.88, 2.37)
Night sweats
 Never 131 7.6 1.00 119 6.9 1.00 18 1.2 1.00
 Early onset 1077 12.1 1.56 (1.26, 1.93) 955 10.7 1.56 (1.24, 1.96) 214 2.4 1.57 (0.95, 2.60)
 Late onset 630 12.8 2.03 (1.62, 2.54) 554 11.1 1.99 (1.57, 2.53) 122 2.5 1.99 (1.18, 3.37)
VMS (hot flushes or/and night sweats)
 Never 101 8 1.00 90 7.1 1.00 15 1.4 1.00
 Early onset 1111 9.4 1.38 (1.10, 1.75) 984 8.3 1.43 (1.12, 1.84) 222 1.9 1.26 (0.73, 2.17)
 Late onset 613 11.5 1.69 (1.33, 2.16) 541 10.1 1.73 (1.33, 2.24) 115 2.2 1.57 (0.89, 2.76)

All HRs were adjusted for age of VMS, race/ethnicity, education, body mass index, smoking status, hypertension status, menopausal hormone therapy status, and menopausal status.

Abbreviations: CVD, cardiovascular disease; CHD, coronary heart disease